Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Monitoring safety indicated that most adverse events were mild to moderate in nature, such as nausea or vomiting
Without the assistance, the body may retain excess weight
In evaluating the application of GLP-1 RAs for the treatment of obesity in children, it is essential to consider the limitations of the existing evidence, as these limitations may significantly impact the reliability and generalizability of research findings
doi: 10.3389/fimmu.2024.1473203 Received 30 July 2024 Accepted 09 September 2024 Published 27 September 2024 Volume 15 - 2024 Edited by Bufu Tang, Fudan University, China Reviewed by Hongquan Wang, Peking University Aerospace School of Clinical Medicine, China Jindong Xie, Sun Yat-sen University Cancer Center (SYSUCC), China Dechao Feng, University College London, United Kingdom Updates Copyright 2024 He, Li, Wu, Liu, Li, Zheng and Lai
US$ 27.22
US$ 20.03
US$ 27.21
US$ 28.04
US$ 27.61
US$ 24.41
